Fig. 2From: Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, SpainFraction of cervical lesions attributable to HPV genotypes targeted by bi-quadrivalent vaccines (HPV 16/18) or nonavalent vaccine (HPV 16/18 and HPV 31/33/45/52/58). *p < 0.001 for the comparison of each HPV group prevalence between CIN2 and CIN3-CISBack to article page